Page 500 - Read Online

Zein et al. Plast Aesthet Res 2020;7:44 I http://dx.doi.org/10.20517/2347-9264.2020.133 Page 9 of 10

22. Doguizi S, Sekeroglu MA, Anayol MA, Yilmazbas P. Central retinal artery occlusion with double cilioretinal artery sparing. Retin Cases
Brief Rep 2019;13:75-8.
23. Chen Y, Wang W, Li J, Yu Y, Li L, et al. Fundus artery occlusion caused by cosmetic facial injections. Chin Med J (Engl)
2014;127:1434-7.
24. Kim A, Kim SH, Kim HJ, Yang HK, Hwang JM, et al. Ophthalmoplegia as a complication of cosmetic facial filler injection. Acta
Ophthalmol 2016;94:e377-9.
25. Bae IH, Kim MS, Choi H, Na CH, Shin BS. Ischemic oculomotor nerve palsy due to hyaluronic acid filler injection. J Cosmet Dermatol
2018;17:1016-8.
26. Dagi Glass LR, Choi CJ, Lee NG. Orbital complication following calcium hydroxylapatite filler injection. Ophthalmic Plast Reconstr
Surg 2017;33:S16-7.
27. Myung Y, Yim S, Jeong JH, Kim BK, Heo CY, et al. The classification and prognosis of periocular complications related to blindness
following cosmetic filler injection. Plast Reconstr Surg 2017;140:61-4.
28. Kim YJ, Kim SS, Song WK, Lee SY, Yoon JS. Ocular ischemia with hypotony after injection of hyaluronic acid gel. Ophthalmic Plast
Reconstr Surg 2011;27:e152-5.
29. Ramesh S, Fiaschetti D, Goldberg RA. Orbital and ocular ischemic syndrome with blindness after facial filler injection. Ophthalmic Plast
Reconstr Surg 2018;34:e108-10.
30. Silva MT, Curi AL. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr
2004;62:873-4.
31. Beleznay K, Carruthers JDA, Humphrey S, Carruthers A, Jones D. Update on avoiding and treating blindness from fillers: a recent review
of the world literature. Aesthet Surg J 2019;39:662-74.
32. Kim YK, Jung C, Woo SJ, Park KH. Cerebral angiographic findings of cosmetic facial filler-related ophthalmic and retinal artery
occlusion. J Korean Med Sci 2015;30:1847-55.
33. Park KH, Kim YK, Woo SJ, Kang SW, Lee WK, et al. Iatrogenic occlusion of the ophthalmic artery after cosmetic facial filler injections:
a national survey by the Korean Retina Society. JAMA Ophthalmol 2014;132:714-23.
34. Barbucci R, Lamponi S, Magnani A, Poletti LF, Rhodes NP, et al. Influence of sulfation on platelet aggregation and activation with
differentially sulfated hyaluronic acids. J Thromb Thrombolysis 1998;6:109-15.
35. Braverman IM, Keh-Yen A. Ultrastructure of the human dermal microcirculation. IV. Valve-containing collecting veins at the dermal-
subcutaneous junction. J Invest Dermatol 1983;81:438-42.
36. Beleznay K, Humphrey S, Carruthers JD, Carruthers A. Vascular compromise from soft tissue augmentation: experience with 12 cases
and recommendations for optimal outcomes. J Clin Aesthet Dermatol 2014;7:37-43.
37. Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers--focal
necrosis and angry red bumps. Dermatol Surg 2006;32:426-34.
38. Landau M. Hyaluronidase caveats in treating filler complications. Dermatol Surg 2015;41 Suppl 1:S347-53.
39. Rullan PP, Olson R, Lee KC. The use of intralesional sodium thiosulfate to dissolve facial nodules from calcium hydroxylapatite.
Dermatol Surg 2019; doi: 10.1097/DSS.000000000000223.
40. Robinson DM. In vitro analysis of the degradation of calcium hydroxylapatite dermal filler: a proof-of-concept study. Dermatol Surg
2018;44 Suppl 1:S5-9.
41. Hwang CJ. Periorbital injectables: understanding and avoiding complications. J Cutan Aesthet Surg 2016;9:73-9.
42. Chesnut C. Restoration of visual loss with retrobulbar hyaluronidase injection after hyaluronic acid filler. Dermatol Surg 2018;44:435-7.
43. Sundaram H, Rohrich RJ, Liew S, Sattler G, Talarico S, et al. Cohesivity of hyaluronic acid fillers: development and clinical implications
of a novel assay, pilot validation with a five-point grading scale, and evaluation of six u.s. food and drug administration-approved fillers.
Plast Reconstr Surg 2015;136:678-86.
44. DeLorenzi C. Complications of injectable fillers, part I. Aesthet Surg J 2013;33:561-75.
45. Rootman DB, Lin JL, Goldberg R. Does the tyndall effect describe the blue hue periodically observed in subdermal hyaluronic acid gel
placement? Ophthalmic Plast Reconstr Surg 2014;30:524-7.
46. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007;33 Suppl 2:S168-75.
47. Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, et al. Foreign body granulomas after all injectable
dermal fillers: part 1. Possible causes. Plast Reconstr Surg 2009;123:1842-63.
48. Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol
2013;6:295-316.
49. Capodiferro S, Sportelli P, Limongelli L, Dell’Olio F, Tempesta A, et al. Delayed sclerosing granulomatous reaction to dermal filler
injection of poly-hydroxyethyl-methacrylate suspended in hyaluronic acid: histochemical and confocal laser scanning microscopical
analysis. Clinical Case Rep 2019;7:2215-9.
50. El-Khalawany M, Fawzy S, Saied A, Al Said M, Amer A, et al. Dermal filler complications: a clinicopathologic study with a spectrum of
histologic reaction patterns. Ann Diagn Pathol 2015;19:10-5.
51. Ledon JA, Savas JA, Yang S, Franca K, Camacho I, et al. Inflammatory nodules following soft tissue filler use: a review of causative
agents, pathology and treatment options. Am J Clin Dermatol 2013;14:401-11.
52. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation.
Aesthetic Plast Surg 2003;27:354-66; discussion 67.
53. Lafaille P, Benedetto A. Fillers: contraindications, side effects and precautions. J Cutan Aesthet Surg 2010;3:16-9.